Investigators at Duke University School of Medicine Report New Data on Kidney Transplants (Off-Label Use of Alemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation - Long-Term Real-World Experience)

Media coverage

• Title	Investigators at Duke University School of Medicine Report New Data on Kidney Transplants (Off-Label Use of Alemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation - Long-Term Real-World Experience)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	1/10/25
  Persons	Allan Kirk